Skip to main content

Myofascial Pain Syndrome

1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Stamford Pharmaceuticals
1 program
1
CapsaicinPhase 21 trial
Active Trials
NCT00795106Withdrawn0Est. Nov 2010
Lundbeck
LundbeckDenmark - Copenhagen
1 program
Dry needlingN/A1 trial
Active Trials
NCT01710735Completed80Est. Sep 2012

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Stamford PharmaceuticalsCapsaicin
LundbeckDry needling

Clinical Trials (2)

Total enrollment: 80 patients across 2 trials

Trial to Evaluate the Efficacy of Topical Capsaicin to Reduce Pain and Improve Health-related Quality of Life in Adults With Chronic Myofascial Neck Pain

Start: Nov 2009Est. completion: Nov 20100
Phase 2Withdrawn

Skeletal Muscle Contractility, Self-reported Pain and Tissue Sensitivity in Females With Neck/Shoulder Pain and Trapezius MFTrPs

Start: Apr 2011Est. completion: Sep 201280 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.